Delivery Order SPE2DB22D3301-SPE2DB24FZ4VV
Award Date
9/25/24
Potential Completion Date
10/17/24
Potential Value
$9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $9,722.10 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of 4,564,743,440 units of the pharmaceutical product GAMUNEX-C 10 GRAM/100 ML VIAL 100ML, with a completion date of June 20, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which allows the...
This federal contract award, valued at $5,982.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 20 GRAM/200 ML VIAL 200ML, a pharmaceutical product, with a performance period extending to May 13, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and does not have a set-aside designation, indicating open competition....
This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $14,295.00 awarded to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the delivery of GAMUNEX-C 20 GRAM/200 ML VIAL 200ML, a pharmaceutical product, with a period of performance through September 26, 2024. AmerisourceBergen is one of the largest pharmaceutical distributors in the United States and has been awarded numerous federal contracts to provide a wide range...
This federal contract award, valued at $86,564.16, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for the supply of GAMUNEX-C 10 GRAM/100 ML VIAL 100ML, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a...
The U.S. Department of Defense (DOD) Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order contract valued at $28,854.48 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution services company. The delivery order is for the product GAMUNEX-C 40 GRAM/400 ML VIAL 400ML and has a period of performance through April 1, 2024. This award is part of a larger $999,999,999.00 indefinite delivery contract (IDC)...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was made to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at up to $57,708.96, is a Delivery Order (DO) for the product "GAMUNEX-C 40 GRAM/400 ML VIAL 400ML" and has a firm fixed price. The contract does not have a set-aside designation. Amerisourcebergen holds a larger...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $6,011.40 delivery order is for the medical product GAMUNEX-C 10 GRAM/100 ML VIAL 100ML, with a completion date of October 16, 2024. The contract has a firm fixed price pricing type and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product GAMUNEX-C 20 GRAM/200 ML VIAL 200ML to the Defense Logistics Agency (DLA). The $14,295.00 firm fixed-price delivery order has a completion date of June 10, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,555.05 firm-fixed-price delivery order is for the supply of GAMUNEX-C 5 GRAM/50 ML VIAL 50ML, a medical product. The contract has an ultimate completion date of July 7, 2025 and was awarded on June 12, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML, a medical product, with a ceiling value of $207,781.44 and a completion date of January 3, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp...